疾病修饰策略:针对多发性硬化症和其他自身免疫性疾病中的蛋白激酶
Franz Felix Konen1, Nora Möhn1, Torsten Witte2
1Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.
Autoimmunity reviews
|January 22, 2025
概括
新的蛋白激酶抑制剂在治疗多发性硬化症 (MS) 和其他自身免疫性疾病方面表现有前途. 这些新疗法可以为患有并存疾病的患者提供个性化治疗计划.
科学领域:
- 神经免疫学 神经免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 治疗正在与新的免疫调节疗法一起发展.
- 基础研究促进了对MS病理学的理解,推动了新药的发现.
研究的目的:
- 在针对自身免疫性疾病的临床试验中审查新型蛋白激酶抑制剂.
- 探索它们作为未来多发性硬化和并发性自身免疫性疾病的治疗方法的潜力.
主要方法:
- 对正在进行的自身免疫性疾病临床试验的文献综述.
- 对向蛋白激酶的药物机制的分析.
主要成果:
- 一些蛋白质激酶抑制剂正在研究中.
- 这些化合物向与自身免疫过程相关的多种途径.
结论:
- 准蛋白激酶为MS治疗提供了一个有前途的途径.
- 个性化医疗方法可能会出现,考虑到并发症.
相关概念视频
Parkinson's Disease: Overview
452
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
452
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


